메뉴 건너뛰기




Volumn 16, Issue 3, 2011, Pages 838-848

Acquired endocrine resistance in breast cancer: Implications for tumour metastasis

Author keywords

Angiogenesis; Breast Cancer; Cell adhesion; Endocrine resistance; Invasion; Metastasis; Migration; Review

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG DERIVATIVE; ESTRADIOL; FULVESTRANT; HERMES ANTIGEN; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR;

EID: 79955004388     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3723     Document Type: Article
Times cited : (25)

References (91)
  • 1
    • 39049192296 scopus 로고    scopus 로고
    • The origin of cancer metastasis
    • J. Carr and I. Carr: The origin of cancer metastasis. Can Bull Med Hist, 22(2), 353-358, (2005)
    • (2005) Can Bull Med Hist , vol.22 , Issue.2 , pp. 353-358
    • Carr, J.1    Carr, I.2
  • 2
    • 0030995179 scopus 로고    scopus 로고
    • Incidence and kinetics of distant metastases in patients with operable breast cancer
    • M. Kryj, B. Maciejewski, H. R. Withers and J. M. Taylor: Incidence and kinetics of distant metastases in patients with operable breast cancer. Neoplasma, 44(1), 3-11, (1997) (Pubitemid 27181811)
    • (1997) Neoplasma , vol.44 , Issue.1 , pp. 3-11
    • Kryj, M.1    Maciejewski, B.2    Withers, H.R.3    Taylor, J.M.G.4
  • 4
    • 27644437566 scopus 로고    scopus 로고
    • Endocrine therapy-current benefits and limitations
    • R. I. Nicholson and S. R. Johnston: Endocrine therapy-current benefits and limitations. Breast Cancer Res Treat, 93 Suppl 1S3-10, (2005)
    • (2005) Breast Cancer Res Treat , vol.93 , Issue.SUPPL. 1
    • Nicholson, R.I.1    Johnston, S.R.2
  • 5
    • 38049014517 scopus 로고    scopus 로고
    • Evolving nonendocrine therapeutic options for metastatic breast cancer: How adjuvant chemotherapy influences treatment
    • P. Conte, V. Guarneri and C. Bengala: Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatment. Clin Breast Cancer, 7(11), 841-849, (2007)
    • (2007) Clin Breast Cancer , vol.7 , Issue.11 , pp. 841-849
    • Conte, P.1    Guarneri, V.2    Bengala, C.3
  • 6
  • 7
    • 42049121934 scopus 로고    scopus 로고
    • Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
    • DOI 10.1210/er.2006-0045
    • G. Arpino, L. Wiechmann, C. K. Osborne and R. Schiff: Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev, 29(2), 217-233, (2008) (Pubitemid 351519691)
    • (2008) Endocrine Reviews , vol.29 , Issue.2 , pp. 217-233
    • Arpino, G.1    Wiechmann, L.2    Osborne, C.K.3    Schiff, R.4
  • 8
    • 11244250660 scopus 로고    scopus 로고
    • Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: New opportunities for therapy
    • DOI 10.1677/erc.1.00778
    • R. I. Nicholson, C. Staka, F. Boyns, I. R. Hutcheson and J. M. Gee: Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. Endocr Relat Cancer, 11(4), 623-641, (2004) (Pubitemid 40065542)
    • (2004) Endocrine-Related Cancer , vol.11 , Issue.4 , pp. 623-641
    • Nicholson, R.I.1    Staka, C.2    Boyns, F.3    Hutcheson, I.R.4    Gee, J.M.W.5
  • 9
    • 0037373326 scopus 로고    scopus 로고
    • Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells
    • DOI 10.1210/en.2002-220620
    • J. M. Knowlden, I. R. Hutcheson, H. E. Jones, T. Madden, J. M. Gee, M. E. Harper, D. Barrow, A. E. Wakeling and R. I. Nicholson: Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology, 144(3), 1032-1044, (2003) (Pubitemid 36262870)
    • (2003) Endocrinology , vol.144 , Issue.3 , pp. 1032-1044
    • Knowlden, J.M.1    Hutcheson, I.R.2    Jones, H.E.3    Madden, T.4    Gee, J.M.W.5    Harper, M.E.6    Barrow, D.7    Wakeling, A.E.8    Nicholson, R.I.9
  • 10
    • 0035664786 scopus 로고    scopus 로고
    • Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer
    • H. Kurokawa and C. L. Arteaga: Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. Clin Cancer Res, 7(12 Suppl), 4436s-4442s; discussion 4411s-4412s, (2001) (Pubitemid 34031593)
    • (2001) Clinical Cancer Research , vol.7 , Issue.12 SUPPL.
    • Kurokawa, H.1    Arteaga, C.L.2
  • 11
    • 26044478813 scopus 로고    scopus 로고
    • Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?
    • DOI 10.1158/1078-0432.CCR-05-0196
    • S. Tovey, B. Dunne, C. J. Witton, A. Forsyth, T. G. Cooke and J. M. Bartlett: Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer? Clin Cancer Res, 11(13), 4835-4842, (2005) (Pubitemid 41557203)
    • (2005) Clinical Cancer Research , vol.11 , Issue.13 , pp. 4835-4842
    • Tovey, S.1    Dunne, B.2    Witton, C.J.3    Forsyth, A.4    Cooke, T.G.5    Bartlett, J.M.S.6
  • 12
    • 0033001742 scopus 로고    scopus 로고
    • Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
    • DOI 10.1038/sj.bjc.6690112
    • J. P. Parisot, X. F. Hu, M. DeLuise and J. R. Zalcberg: Altered expression of the IGF-1 receptor in a tamoxifenresistant human breast cancer cell line. Br J Cancer, 79(5-6), 693-700, (1999) (Pubitemid 29082092)
    • (1999) British Journal of Cancer , vol.79 , Issue.5-6 , pp. 693-700
    • Parisot, J.P.1    Hu, X.F.2    DeLuise, M.3    Zalcberg, J.R.4
  • 14
    • 24744471000 scopus 로고    scopus 로고
    • Evolving understanding of growth regulation in human breast cancer: Interactions of the steroid and peptide growth regulatory pathways
    • DOI 10.1093/jnci/dji288
    • C. A. Wilson and D. J. Slamon: Evolving understanding of growth regulation in human breast cancer: interactions of the steroid and peptide growth regulatory pathways. J Natl Cancer Inst, 97(17), 1238-1239, (2005) (Pubitemid 41535357)
    • (2005) Journal of the National Cancer Institute , vol.97 , Issue.17 , pp. 1238-1239
    • Wilson, C.A.1    Slamon, D.J.2
  • 15
    • 0036266077 scopus 로고    scopus 로고
    • Growth factor-induced cell motility in tumor invasion
    • DOI 10.1080/028418602753669481
    • A. Wells, J. Kassis, J. Solava, T. Turner and D. A. Lauffenburger: Growth factor-induced cell motility in tumor invasion. Acta Oncol, 41(2), 124-130, (2002) (Pubitemid 34557071)
    • (2002) Acta Oncologica , vol.41 , Issue.2 , pp. 124-130
    • Wells, A.1    Kassis, J.2    Solava, J.3    Turner, T.4    Lauffenburger, D.A.5
  • 16
    • 44949117528 scopus 로고    scopus 로고
    • Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
    • DOI 10.1002/ijc.23465
    • Y. Ueno, H. Sakurai, S. Tsunoda, M. K. Choo, M. Matsuo, K. Koizumi, I. Saiki, P. Arora, B. D. Cuevas, A. Russo, G. L. Johnson and J. Trejo: Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells Int J Cancer, 123(2), 340-347, (2008) (Pubitemid 351842018)
    • (2008) International Journal of Cancer , vol.123 , Issue.2 , pp. 340-347
    • Ueno, Y.1    Sakurai, H.2    Tsunoda, S.3    Choo, M.-K.4    Matsuo, M.5    Koizumi, K.6    Saiki, I.7
  • 17
    • 47949089905 scopus 로고    scopus 로고
    • Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
    • P. Arora, B. D. Cuevas, A. Russo, G. L. Johnson and J. Trejo: Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene, 27(32), 4434-4445, (2008)
    • (2008) Oncogene , vol.27 , Issue.32 , pp. 4434-4445
    • Arora, P.1    Cuevas, B.D.2    Russo, A.3    Johnson, G.L.4    Trejo, J.5
  • 18
    • 4344705051 scopus 로고    scopus 로고
    • Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib ('Iressa', ZD1839)
    • DOI 10.1023/B:CLIN.0000037697.76011.1d
    • S. Hiscox, L. Morgan, D. Barrow, C. Dutkowskil, A. Wakeling and R. I. Nicholson: Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839). Clin Exp Metastasis, 21(3), 201-212, (2004) (Pubitemid 39158497)
    • (2004) Clinical and Experimental Metastasis , vol.21 , Issue.3 , pp. 201-212
    • Hiscox, S.1    Morgan, L.2    Barrow, D.3    Dutkowski, C.4    Wakeling, A.5    Nicholson, R.I.6
  • 19
    • 28844494352 scopus 로고    scopus 로고
    • Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation
    • DOI 10.1002/ijc.21355
    • S. Hiscox, W. G. Jiang, K. Obermeier, K. Taylor, L. Morgan, R. Burmi, D. Barrow and R. I. Nicholson: Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer, 118(2), 290-301, (2006) (Pubitemid 41779067)
    • (2006) International Journal of Cancer , vol.118 , Issue.2 , pp. 290-301
    • Hiscox, S.1    Jiang, W.G.2    Obermeier, K.3    Taylor, K.4    Morgan, L.5    Burmi, R.6    Barrow, D.7    Nicholson, R.I.8
  • 20
    • 33846811714 scopus 로고    scopus 로고
    • Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: Implications for tumour-stroma interactions
    • DOI 10.1677/erc.1.01270
    • S. Hiscox, N. J. Jordan, W. Jiang, M. Harper, R. McClelland, C. Smith and R. I. Nicholson: Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions. Endocr Relat Cancer, 13(4), 1085-1099, (2006) (Pubitemid 46212564)
    • (2006) Endocrine-Related Cancer , vol.13 , Issue.4 , pp. 1085-1099
    • Hiscox, S.1    Jordan, N.J.2    Jiang, W.3    Harper, M.4    McClelland, R.5    Smith, C.6    Nicholson, R.I.7
  • 21
    • 19944427176 scopus 로고    scopus 로고
    • Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iresa) in human breast and prostate cancer cells
    • DOI 10.1677/erc.1.00799
    • H. E. Jones, L. Goddard, J. M. Gee, S. Hiscox, M. Rubini, D. Barrow, J. M. Knowlden, S. Williams, A. E. Wakeling and R. I. Nicholson: Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocr Relat Cancer, 11(4), 793-814, (2004) (Pubitemid 40065552)
    • (2004) Endocrine-Related Cancer , vol.11 , Issue.4 , pp. 793-814
    • Jones, H.E.1    Goddard, L.2    Gee, J.M.W.3    Hiscox, S.4    Rubini, M.5    Barrow, D.6    Knowlden, J.M.7    Williams, S.8    Wakeling, A.E.9    Nicholson, R.I.10
  • 24
    • 59349115555 scopus 로고    scopus 로고
    • Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity
    • Y. Zhao and M. D. Planas-Silva: Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity. Cancer Lett, 275(2), 204-212, (2009)
    • (2009) Cancer Lett , vol.275 , Issue.2 , pp. 204-212
    • Zhao, Y.1    Planas-Silva, M.D.2
  • 25
    • 79959585615 scopus 로고    scopus 로고
    • Src-dependent changes in beta-catenin activity promote a migratory phenotype in endocrine-resistant breast cancer cells
    • A. Wadhawan, P. Barrett-Lee, C. Smith, R. I. Nicholson and S. Hiscox: Src-Dependent Changes in Beta-Catenin Activity Promote a Migratory Phenotype in Endocrine-Resistant Breast Cancer Cells. Cancer Research, 69(S), 5143, (2009)
    • (2009) Cancer Research , vol.69 , Issue.S , pp. 5143
    • Wadhawan, A.1    Barrett-Lee, P.2    Smith, C.3    Nicholson, R.I.4    Hiscox, S.5
  • 26
    • 70349142286 scopus 로고    scopus 로고
    • Tyrosine-phosphorylation of the 12th armadillo-repeat of beta-catenin is associated with cadherin dysfunction in human cancer
    • K. Shomori, A. Ochiai, S. Akimoto, Y. Ino, K. Shudo, H. Ito and S. Hirohashi: Tyrosine-phosphorylation of the 12th armadillo-repeat of beta-catenin is associated with cadherin dysfunction in human cancer. Int J Oncol, 35(3), 517-524, (2009)
    • (2009) Int J Oncol , vol.35 , Issue.3 , pp. 517-524
    • Shomori, K.1    Ochiai, A.2    Akimoto, S.3    Ino, Y.4    Shudo, K.5    Ito, H.6    Hirohashi, S.7
  • 27
    • 79959618833 scopus 로고    scopus 로고
    • Inhibition of Src kinase restores cell-cell adhesion and suppresses the aggressive phenotype of endocrine-resistant breast cancer cells
    • Sumbitted
    • A. Wadhawan, C. Smith, N. J. Jordan, P. Barrett-Lee and S. Hiscox: Inhibition of Src kinase restores cell-cell adhesion and suppresses the aggressive phenotype of endocrine-resistant breast cancer cells. Breast Cancer Res, Sumbitted, (2008)
    • (2008) Breast Cancer Res
    • Wadhawan, A.1    Smith, C.2    Jordan, N.J.3    Barrett-Lee, P.4    Hiscox, S.5
  • 28
    • 33744791463 scopus 로고    scopus 로고
    • Wnt signaling: Is the party in the nucleus?
    • DOI 10.1101/gad.1424006
    • K. Willert and K. A. Jones: Wnt signaling: is the party in the nucleus? Genes Dev, 20(11), 1394-1404, (2006) (Pubitemid 43830647)
    • (2006) Genes and Development , vol.20 , Issue.11 , pp. 1394-1404
    • Willert, K.1    Jones, K.A.2
  • 29
    • 79959574626 scopus 로고    scopus 로고
    • Reduction of in vitro metastatic potential of tamoxifenresistant breast cancer cells following inhibition of src kinase activity by AZD0530
    • S. Hiscox, L. Morgan, T. Green and R. I. Nicholson: Reduction of in vitro metastatic potential of tamoxifenresistant breast cancer cells following inhibition of src kinase activity by AZD0530. Eur J Cancer, 2(8), 121-122, (2004)
    • (2004) Eur J Cancer , vol.2 , Issue.8 , pp. 121-122
    • Hiscox, S.1    Morgan, L.2    Green, T.3    Nicholson, R.I.4
  • 30
    • 34249776956 scopus 로고    scopus 로고
    • Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
    • DOI 10.1007/s10585-007-9065-y
    • S. Hiscox, N. J. Jordan, L. Morgan, T. P. Green and R. I. Nicholson: Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clin Exp Metastasis, 24(3), 157-167, (2007) (Pubitemid 46850227)
    • (2007) Clinical and Experimental Metastasis , vol.24 , Issue.3 , pp. 157-167
    • Hiscox, S.1    Jordan, N.J.2    Morgan, L.3    Green, T.P.4    Nicholson, R.I.5
  • 31
    • 79959594043 scopus 로고    scopus 로고
    • CD44-Activated HER-2 Signalling in Tamoxifen Resistant Breast Cancer Cells Promotes a Migratory Phenotype
    • B. Baruha, P. Barrett-Lee, C. Smith, R. I. Nicholson and S. Hiscox: CD44-Activated HER-2 Signalling in Tamoxifen Resistant Breast Cancer Cells Promotes a Migratory Phenotype. Cancer Res, 69(S), 5472, (2009)
    • (2009) Cancer Res , vol.69 , Issue.S , pp. 5472
    • Baruha, B.1    Barrett-Lee, P.2    Smith, C.3    Nicholson, R.I.4    Hiscox, S.5
  • 32
    • 0038386685 scopus 로고    scopus 로고
    • Epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland
    • DOI 10.1186/bcr615
    • S. Z. Haslam and T. L. Woodward: Host microenvironment in breast cancer development: epithelialcell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res, 5(4), 208-215, (2003) (Pubitemid 36818163)
    • (2003) Breast Cancer Research , vol.5 , Issue.4 , pp. 208-215
    • Haslam, S.Z.1    Woodward, T.L.2
  • 34
    • 33846554255 scopus 로고    scopus 로고
    • Focal adhesion kinase: A potential target in cancer therapy
    • M. J. van Nimwegen and B. van de Water: Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol, 73(5), 597-609, (2007)
    • (2007) Biochem Pharmacol , vol.73 , Issue.5 , pp. 597-609
    • Van Nimwegen, M.J.1    Van De Weter, B.2
  • 36
    • 0029739950 scopus 로고    scopus 로고
    • Control of adhesion-dependent cell survival by focal adhesion kinase
    • S. M. Frisch, K. Vuori, E. Ruoslahti and P. Y. Chan-Hui: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol, 134(3), 793-799, (1996) (Pubitemid 26269148)
    • (1996) Journal of Cell Biology , vol.134 , Issue.3 , pp. 793-799
    • Frisch, S.M.1    Vuori, K.2    Ruoslahti, E.3    Chan-Hui, P.-Y.4
  • 38
    • 19644388523 scopus 로고    scopus 로고
    • Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation
    • DOI 10.1158/0008-5472.CAN-04-4126
    • M. J. van Nimwegen, S. Verkoeijen, L. van Buren, D. Burg and B. van de Water: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res, 65(11), 4698-4706, (2005) (Pubitemid 40740806)
    • (2005) Cancer Research , vol.65 , Issue.11 , pp. 4698-4706
    • Van Nimwegen, M.J.1    Verkoeijen, S.2    Van Buren, L.3    Burg, D.4    Van De Water, B.5
  • 40
    • 0037237066 scopus 로고    scopus 로고
    • Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: Immunohistochemistry and real-time PCR analyses
    • A. L. Lark, C. A. Livasy, B. Calvo, L. Caskey, D. T. Moore, X. Yang and W. G. Cance: Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res, 9(1), 215-222, (2003) (Pubitemid 36109736)
    • (2003) Clinical Cancer Research , vol.9 , Issue.1 , pp. 215-222
    • Lark, A.L.1    Livasy, C.A.2    Calvo, B.3    Caskey, L.4    Moore, D.T.5    Yang, X.6    Cance, W.G.7
  • 41
    • 0242491536 scopus 로고    scopus 로고
    • Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx
    • DOI 10.1097/00005537-200311000-00017
    • M. S. Aronsohn, H. M. Brown, G. Hauptman and L. J. Kornberg: Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope, 113(11), 1944-1948, (2003) (Pubitemid 37409682)
    • (2003) Laryngoscope , vol.113 , Issue.11 , pp. 1944-1948
    • Aronsohn, M.S.1    Brown, H.M.2    Hauptman, G.3    Kornberg, L.J.4
  • 43
    • 29044442658 scopus 로고    scopus 로고
    • Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma
    • DOI 10.1016/j.humpath.2005.09.024, PII S0046817705005319
    • R. Madan, M. B. Smolkin, R. Cocker, R. Fayyad and M. H. Oktay: Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol, 37(1), 9-15, (2006) (Pubitemid 41790497)
    • (2006) Human Pathology , vol.37 , Issue.1 , pp. 9-15
    • Madan, R.1    Smolkin, M.B.2    Cocker, R.3    Fayyad, R.4    Oktay, M.H.5
  • 44
    • 79952773417 scopus 로고    scopus 로고
    • Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells
    • Mar 31. [Epub ahead of print]
    • S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen, R. I. Nicholson and P. Barrett-Lee: Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells. Breast Cancer Res Treat, 2010 Mar 31. [Epub ahead of print]
    • (2010) Breast Cancer Res Treat
    • Hiscox, S.1    Barnfather, P.2    Hayes, E.3    Bramble, P.4    Christensen, J.5    Nicholson, R.I.6    Barrett-Lee, P.7
  • 45
    • 34447276000 scopus 로고    scopus 로고
    • Tumor microenvironment: The role of the tumor stroma in cancer
    • DOI 10.1002/jcb.21159
    • H. Li, X. Fan and J. Houghton: Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem, 101(4), 805-815, (2007) (Pubitemid 47040863)
    • (2007) Journal of Cellular Biochemistry , vol.101 , Issue.4 , pp. 805-815
    • Li, H.1    Fan, X.2    Houghton, J.3
  • 46
    • 12344328353 scopus 로고    scopus 로고
    • Tumor-stroma interactions
    • DOI 10.1016/j.gde.2004.12.003, PII S0959437X04001893, Oncogenes and Cell Proliferation
    • N. A. Bhowmick and H. L. Moses: Tumor-stroma interactions. Curr Opin Genet Dev, 15(1), 97-101, (2005) (Pubitemid 40127637)
    • (2005) Current Opinion in Genetics and Development , vol.15 , Issue.1 , pp. 97-101
    • Bhowmick, N.A.1    Moses, H.L.2
  • 47
    • 9244227134 scopus 로고    scopus 로고
    • Stromal fibroblasts in cancer initiation and progression
    • DOI 10.1038/nature03096
    • N. A. Bhowmick, E. G. Neilson and H. L. Moses: Stromal fibroblasts in cancer initiation and progression. Nature, 432(7015), 332-337, (2004) (Pubitemid 39551661)
    • (2004) Nature , vol.432 , Issue.7015 , pp. 332-337
    • Bhowmick, N.A.1    Neilson, E.G.2    Moses, H.L.3
  • 48
    • 44449151030 scopus 로고    scopus 로고
    • Drug development of MET inhibitors: Targeting oncogene addiction and expedience
    • DOI 10.1038/nrd2530, PII NRD2530
    • P. M. Comoglio, S. Giordano and L. Trusolino: Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov, 7(6), 504-516, (2008) (Pubitemid 351767118)
    • (2008) Nature Reviews Drug Discovery , vol.7 , Issue.6 , pp. 504-516
    • Comoglio, P.M.1    Giordano, S.2    Trusolino, L.3
  • 49
    • 0141566669 scopus 로고    scopus 로고
    • Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET
    • W. G. Jiang, D. Grimshaw, T. A. Martin, G. Davies, C. Parr, G. Watkins, J. Lane, R. Abounader, J. Laterra and R. E. Mansel: Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clin Cancer Res, 9(11), 4274-4281, (2003) (Pubitemid 37204049)
    • (2003) Clinical Cancer Research , vol.9 , Issue.11 , pp. 4274-4281
    • Jiang, W.G.1    Grimshaw, D.2    Martin, T.A.3    Davies, G.4    Parr, C.5    Watkins, G.6    Lane, J.7    Abounader, R.8    Laterra, J.9    Mansel, R.E.10
  • 50
    • 79959586534 scopus 로고    scopus 로고
    • Increased matrix metalloproteinae (MMP) expression in anti-oestrogen resistant breast carcinoma cell lines
    • Y. Khirwadkar, N. Jordan, S. Hiscox and R. Nicholcon: Increased matrix metalloproteinae (MMP) expression in anti-oestrogen resistant breast carcinoma cell lines. Eur J Cancer, 3P19, (2005)
    • (2005) Eur J Cancer , vol.3 , pp. 19
    • Khirwadkar, Y.1    Jordan, N.2    Hiscox, S.3    Nicholcon, R.4
  • 52
    • 0036595629 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transitions in tumour progression
    • J. P. Thiery: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2(6), 442-454, (2002)
    • (2002) Nat Rev Cancer , vol.2 , Issue.6 , pp. 442-454
    • Thiery, J.P.1
  • 53
    • 0032523074 scopus 로고    scopus 로고
    • Expression of c-met is a strong independent prognostic factor in breast carcinoma
    • DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0. CO;2-7
    • R. A. Ghoussoub, D. A. Dillon, T. D'Aquila, E. B. Rimm, E. R. Fearon and D. L. Rimm: Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer, 82(8), 1513-1520, (1998) (Pubitemid 28164998)
    • (1998) Cancer , vol.82 , Issue.8 , pp. 1513-1520
    • Ghoussoub, R.A.D.1    Dillon, D.A.2    D'Aquila, T.3    Rimm, E.B.4    Fearon, E.R.5    Rimm, D.L.6
  • 54
    • 11144324910 scopus 로고    scopus 로고
    • Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells
    • DOI 10.1152/ajprenal.00318.2003
    • X. Zhang, J. Yang, Y. Li and Y. Liu: Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol, 288(1), F16-26, (2005) (Pubitemid 40038672)
    • (2005) American Journal of Physiology - Renal Physiology , vol.288 , Issue.1-57
    • Zhang, X.1    Yang, J.2    Li, Y.3    Liu, Y.4
  • 56
    • 15544365184 scopus 로고    scopus 로고
    • Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by flourescence resonance energy transfer
    • DOI 10.1210/me.2004-0326
    • K. Kim, R. Barhoumi, R. Burghardt and S. Safe: Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol Endocrinol, 19(4), 843-854, (2005) (Pubitemid 40403092)
    • (2005) Molecular Endocrinology , vol.19 , Issue.4 , pp. 843-854
    • Kim, K.1    Barhoumi, R.2    Burghardt, R.3    Safe, S.4
  • 57
    • 12844287625 scopus 로고    scopus 로고
    • Sp1 transcription factor expression is regulated by estrogen-related receptor alpha1
    • DOI 10.1016/j.bbrc.2004.12.165, PII S0006291X04029961
    • D. Sumi and L. J. Ignarro: Sp1 transcription factor expression is regulated by estrogen-related receptor alpha1. Biochem Biophys Res Commun, 328(1), 165-172, (2005) (Pubitemid 40164650)
    • (2005) Biochemical and Biophysical Research Communications , vol.328 , Issue.1 , pp. 165-172
    • Sumi, D.1    Ignarro, L.J.2
  • 58
    • 13544271667 scopus 로고    scopus 로고
    • Waf1 gene transcription through releasing histone deacetylase 1 and betrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line
    • DOI 10.1074/jbc.M408063200
    • R. Varshochi, F. Halim, A. Sunters, J. P. Alao, P. A. Madureira, S. M. Hart, S. Ali, D. M. Vigushin, R. C. Coombes and E. W. Lam: ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. J Biol Chem, 280(5), 3185-3196, (2005) (Pubitemid 40223780)
    • (2005) Journal of Biological Chemistry , vol.280 , Issue.5 , pp. 3185-3196
    • Varshochi, R.1    Halim, F.2    Sunters, A.3    Alao, J.P.4    Madureira, P.A.5    Hart, S.M.6    Ali, S.7    Vigushin, D.M.8    Coombes, R.C.9    Lam, E.W.-F.10
  • 59
    • 34948870439 scopus 로고    scopus 로고
    • Upregulation of CD44s and variants in anti-hormone resistant breast cancer cells
    • M. E. Harper, C. Smith and R. I. Nicholson: Upregulation of CD44s and variants in anti-hormone resistant breast cancer cells. Eur J Cancer, 3A71, (2005)
    • (2005) Eur J Cancer , vol.3 A71
    • Harper, M.E.1    Smith, C.2    Nicholson, R.I.3
  • 62
  • 64
    • 13244261126 scopus 로고    scopus 로고
    • Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast
    • DOI 10.1111/j.1365-2559.2004.01981.x
    • Y. Gong, X. Sun, L. Huo, E. L. Wiley and M. S. Rao: Expression of cell adhesion molecules, CD44s and Ecadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology, 46(1), 24-30, (2005) (Pubitemid 40193694)
    • (2005) Histopathology , vol.46 , Issue.1 , pp. 24-30
    • Gong, Y.1    Sun, X.2    Huo, L.3    Wiley, E.L.4    Rao, M.S.5
  • 65
    • 38349026544 scopus 로고    scopus 로고
    • In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver
    • A. Ouhtit, Z. Y. Abd Elmageed, M. E. Abdraboh, T. F. Lioe and M. H. Raj: In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol, 171(6), 2033-2039, (2007)
    • (2007) Am J Pathol , vol.171 , Issue.6 , pp. 2033-2039
    • Ouhtit, A.1    Abd Elmageed, Z.Y.2    Abdraboh, M.E.3    Lioe, T.F.4    Raj, M.H.5
  • 66
    • 79959617446 scopus 로고    scopus 로고
    • Overexpression of CD44 accompanies acquired tamoxifen resistance and potentiates Her2 invasive signaling
    • L. Goddard, N. Jordan, C. Smith, R. I. Nicholson and S. Hiscox: Overexpression of CD44 accompanies acquired tamoxifen resistance and potentiates Her2 invasive signaling. Submitted, (2008)
    • (2008) Submitted
    • Goddard, L.1    Jordan, N.2    Smith, C.3    Nicholson, R.I.4    Hiscox, S.5
  • 67
    • 79959610820 scopus 로고    scopus 로고
    • CD44 is overexpressed in fulvestrant-resistant breast cancer cells: Potentiation of response to HGF
    • N. J. Jordan, C. Smith, J. Gee, R. I. Nicholson and S. Hiscox: CD44 is overexpressed in fulvestrant-resistant breast cancer cells: potentiation of response to HGF. Submitted, (2008)
    • (2008) Submitted
    • Jordan, N.J.1    Smith, C.2    Gee, J.3    Nicholson, R.I.4    Hiscox, S.5
  • 69
    • 0030783518 scopus 로고    scopus 로고
    • Interaction between the adhesion receptor, CD44, and the oncogene product, p185(HER2), promotes human ovarian tumor cell activation
    • DOI 10.1074/jbc.272.44.27913
    • L. Y. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang and M. C. Hung: Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem, 272(44), 27913-27918, (1997) (Pubitemid 27473595)
    • (1997) Journal of Biological Chemistry , vol.272 , Issue.44 , pp. 27913-27918
    • Bourguignon, L.Y.W.1    Zhu, H.2    Chu, A.3    Iida, N.4    Zhang, L.5    Hung, M.-C.6
  • 70
    • 0036342722 scopus 로고    scopus 로고
    • EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines
    • D. Tsatas, V. Kanagasundaram, A. Kaye and U. Novak: EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci, 9(3), 282-288, (2002)
    • (2002) J Clin Neurosci , vol.9 , Issue.3 , pp. 282-288
    • Tsatas, D.1    Kanagasundaram, V.2    Kaye, A.3    Novak, U.4
  • 71
    • 44749090941 scopus 로고    scopus 로고
    • Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
    • B. P. Toole and M. G. Slomiany: Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol, 18(4), 244-250, (2008)
    • (2008) Semin Cancer Biol , vol.18 , Issue.4 , pp. 244-250
    • Toole, B.P.1    Slomiany, M.G.2
  • 72
    • 33744767934 scopus 로고    scopus 로고
    • Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
    • S. Hiscox, L. Morgan, T. P. Green, D. Barrow, J. Gee and R. I. Nicholson: Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res Treat 1-12, (2005)
    • (2005) Breast Cancer Res Treat , pp. 1-12
    • Hiscox, S.1    Morgan, L.2    Green, T.P.3    Barrow, D.4    Gee, J.5    Nicholson, R.I.6
  • 73
    • 31044447246 scopus 로고    scopus 로고
    • Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer
    • DOI 10.1016/j.bbrc.2005.12.164, PII S0006291X05029128
    • M. D. Planas-Silva, R. D. Bruggeman, R. T. Grenko and J. Stanley Smith: Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochem Biophys Res Commun, 341(1), 73-81, (2006) (Pubitemid 43118368)
    • (2006) Biochemical and Biophysical Research Communications , vol.341 , Issue.1 , pp. 73-81
    • Planas-Silva, M.D.1    Bruggeman, R.D.2    Grenko, R.T.3    Stanley Smith, J.4
  • 75
    • 33847023585 scopus 로고    scopus 로고
    • Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells
    • P. Fan, J. Wang, R. J. Santen and W. Yue: Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res, 67(3), 1352-1360, (2007)
    • (2007) Cancer Res , vol.67 , Issue.3 , pp. 1352-1360
    • Fan, P.1    Wang, J.2    Santen, R.J.3    Yue, W.4
  • 81
    • 33846870586 scopus 로고    scopus 로고
    • Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer
    • DOI 10.1677/erc.1.01297
    • S. Hiscox, L. Morgan, T. Green and R. I. Nicholson: Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocr Relat Cancer, 13 Suppl 1S53-59, (2006) (Pubitemid 46222445)
    • (2006) Endocrine-Related Cancer , vol.13 , Issue.SUPPL. 1
    • Hiscox, S.1    Morgan, L.2    Green, T.3    Nicholson, R.I.4
  • 82
    • 0038386613 scopus 로고    scopus 로고
    • Src family kinases in tumor progression and metastasis
    • DOI 10.1023/A:1023772912750
    • J. M. Summy and G. E. Gallick: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev, 22(4), 337-358, (2003) (Pubitemid 36791891)
    • (2003) Cancer and Metastasis Reviews , vol.22 , Issue.4 , pp. 337-358
    • Summy, J.M.1    Gallick, G.E.2
  • 85
    • 24644447079 scopus 로고    scopus 로고
    • The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin
    • DOI 10.1016/j.ceb.2005.08.009, PII S0955067405001122
    • J. Lilien and J. Balsamo: The regulation of cadherinmediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol, 17(5), 459-465, (2005) (Pubitemid 41267159)
    • (2005) Current Opinion in Cell Biology , vol.17 , Issue.5 SPEC. ISS. , pp. 459-465
    • Lilien, J.1    Balsamo, J.2
  • 87
    • 33748286819 scopus 로고    scopus 로고
    • Integrin-regulated FAK-Src signaling in normal and cancer cells
    • DOI 10.1016/j.ceb.2006.08.011, PII S0955067406001220
    • S. K. Mitra and D. D. Schlaepfer: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol, 18(5), 516-523, (2006) (Pubitemid 44332916)
    • (2006) Current Opinion in Cell Biology , vol.18 , Issue.5 , pp. 516-523
    • Mitra, S.K.1    Schlaepfer, D.D.2
  • 88
    • 33645072205 scopus 로고    scopus 로고
    • Treatment for advanced tumors: SRC reclaims center stage
    • J. M. Summy and G. E. Gallick: Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res, 12(5), 1398-1401, (2006)
    • (2006) Clin Cancer Res , vol.12 , Issue.5 , pp. 1398-1401
    • Summy, J.M.1    Gallick, G.E.2
  • 89
    • 33644647192 scopus 로고    scopus 로고
    • Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
    • DOI 10.2353/ajpath.2006.050570
    • J. G. Trevino, J. M. Summy, D. P. Lesslie, N. U. Parikh, D. S. Hong, F. Y. Lee, N. J. Donato, J. L. Abbruzzese, C. H. Baker and G. E. Gallick: Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol, 168(3), 962-972, (2006) (Pubitemid 43327748)
    • (2006) American Journal of Pathology , vol.168 , Issue.3 , pp. 962-972
    • Trevino, J.G.1    Summy, J.M.2    Lesslie, D.P.3    Parikh, N.U.4    Hong, D.S.5    Lee, F.Y.6    Donato, N.J.7    Abbruzzese, J.L.8    Baker, C.H.9    Gallick, G.E.10
  • 91
    • 33748953871 scopus 로고    scopus 로고
    • The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association
    • DOI 10.1254/jphs.FP0060357
    • N. Ali, M. Yoshizumi, S. Yano, S. Sone, H. Ohnishi, K. Ishizawa, Y. Kanematsu, K. Tsuchiya and T. Tamaki: The novel Src kinase inhibitor M475271 inhibits VEGFinduced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association. J Pharmacol Sci, 102(1), 112-120, (2006) (Pubitemid 44440974)
    • (2006) Journal of Pharmacological Sciences , vol.102 , Issue.1 , pp. 112-120
    • Ali, N.1    Yoshizumi, M.2    Yano, S.3    Sone, S.4    Ohnishi, H.5    Ishizawa, K.6    Kanematsu, Y.7    Tsuchiya, K.8    Tamaki, T.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.